Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
New Season of “I am BIO” Podcast Explores Patient…
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…
BIO Statement On Selected Drugs in Medicare under…
The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):“While the Inflation…
Sylvia Wulf to Serve as Interim Lead of BIO's…
WASHINGTON, D.C., July 25, 2024—Today, the Biotechnology Innovation Organization (BIO) announced the appointment of longtime biotechnology executive Sylvia Wulf to lead the Agriculture & Environment Center of Excellence (AECOE). The AECOE…
All Press Releases
  • Show All
Search
Results
Event Tags
October 28, 2022
Washington, D.C. (October 28, 2022) – BIO is disappointed to hear Mexico intends to proceed with its plan to arbitrarily restrict imports of biotech corn. While Mexico states that Brazil, Argentina, and other countries may appear to be alternative…
October 26, 2022
The Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) today released new data on the bioscience industry in the United States. The new report, The U.S. Bioscience Industry: Fostering Innovation and…
October 14, 2022
After the White House announced plans to sign an Executive Order directing the Department of Health and Human Services (HHS)  to explore additional actions to lower prescription drug costs, Nick Shipley, Chief Advocacy Officer at the…
October 10, 2022
  The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to…
October 10, 2022
Today, Dr. Michelle McMurry-Heath informed the Biotechnology Innovation Organization (BIO) Executive Committee that she is stepping down from her position as President and Chief Executive Officer effective October 11, 2022, and she has agreed to…
October 3, 2022
Washington, D.C. (October 3, 2022) – Today, a coalition of leading food and agriculture industry stakeholders in both Mexico and the United States released a new study revealing the broad impacts of Mexico’s proposed ban on biotech corn. The report,…
September 22, 2022
Biotechnology Industry Organization (BIO) President and CEO, Dr. Michelle McMurry-Heath, released the following statement following the announcement that Congress reached an agreement on the Prescription Drug User Fee Act (PDUFA): “For 30…
September 12, 2022
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization, released the following statement in response to the Biden Administration’s “Advancing Biotechnology and Biomanufacturing” Executive Order: “BIO welcomes…
September 8, 2022
As the Biden Administration begins implementation of the Inflation Reduction Act, the Biotechnology Innovation Organization today called on the administration to take additional steps to foster the development and deployment of pioneering…
August 15, 2022
The Impact Ag & Environment Conference hosted by the Biotechnology Innovation Organization has been canceled for 2022. BIO is shifting its focus to planning a must-attend conference in Raleigh, N.C., in September 2023.   BIO had planned…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.